DUBLIN–(BUSINESS WIRE)–The “Neurology Devices Market 2019-2025” report has been added to ResearchAndMarkets.com’s offering. The global neurology devices market is…

DUBLIN–(BUSINESS WIRE)–The “Neurology Devices Market 2019-2025” report has been added to ResearchAndMarkets.com’s offering. The global neurology devices market is…

LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP), a premier developer of drug discovery and development software for modeling and simulation software products…

Recently announced positive topline results in HER2 exon 20 insertion mutations from Cohort 2 of the poziotinib ZENITH20 trial Company is in process of requesting a pre-NDA meeting with the…

Management to host conference call at 4:30 pm EDT today CLEVELAND–(BUSINESS WIRE)–$ATHX #Athersys–Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the…

DUBLIN–(BUSINESS WIRE)–The “Neurology Devices Market 2019-2025” report has been added to ResearchAndMarkets.com’s offering. The global neurology devices market is…

– NDA Filing Accepted by U.S. FDA for Tivozanib as a Treatment of Relapsed or Refractory Renal Cell Carcinoma; Assigned PDUFA Target Action Date of March 31, 2021 – –…

2Q Combined Revenue Record of $33.0 Million, an Increase of 71% YoY, up 14% Sequentially Combined Gross Margin of 36.1%, Reflecting Increase of 800 Basis Points (“BP”) YoY, up 480 BP…

Broad Partnership Features Global Commercialization and Financing Arrangements with Leader in Blood Glucose Monitoring Company has Entered into Financing Agreements for up to $80 Million to…

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of…